Continuation Breakout Analysis — 2026-03-11

Overview

Today delivered 59 continuation breakout signals, marking a robust day for momentum-driven opportunities. The quality appears mixed but compelling, with several high-conviction setups emerging from energy, biotech, and medical sectors. Notable strength indicators include SOC’s explosive 15.1% move on 3.2x relative volume and DTCX’s impressive 13.2% gain with 1.7x RVOL. The diversity across sectors—from energy to healthcare to retail—suggests broad-based momentum rather than sector-specific rotation.

Top 5 Picks

SOC ($16.58) — Energy/Oil&Gas-Integrated

Technical Setup: SOC presents the most compelling breakout signal today with a massive 15.1% surge on 3.2x relative volume and positive ATR momentum (+6.8%). Currently positioned between key zones, the stock has substantial room to run toward the $18.39-$20.74 supply zone. The 8.4 strength demand zone at $13.92-$14.41 provides excellent downside support.

Level	Price	Notes
Entry	$16.50-$16.70	Current breakout zone
Stop Loss	$14.25	Below demand zone
Target	$18.50	Supply zone approach

Institutional Backing: 209 funds provide solid institutional support for this energy play.

DTCX ($3.00) — Financial/Financial Data & Stock Exchanges

Open full analysis on WaveFinder →

Technical Setup: This financial services play shows exceptional momentum with 13.2% gains on 1.7x volume. Positioned between zones with immediate supply resistance at $3.11. The daily demand zone at $2.42-$2.67 sits well below current levels, indicating strong upside momentum continuation potential.

Level	Price	Notes
Entry	$2.95-$3.05	Above supply break
Stop Loss	$2.65	Demand zone protection
Target	$3.35	Next resistance level

Institutional Backing: 11 funds—limited but focused institutional interest.

MEDP ($477.72) — Medical/Medical-Research Equipment

Open full analysis on WaveFinder →

Technical Setup: MEDP offers a lower-risk continuation play with solid 2.3% gains from a strong demand zone. The daily demand at $460-$470.59 provides excellent support, while the distant supply zone at $530-$547 offers significant upside potential. Lower volatility (73.4% ATR risk) makes this ideal for conservative momentum traders.

Level	Price	Notes
Entry	$475-$480	Demand zone breakout
Stop Loss	$455	Below demand support
Target	$520	Toward supply zone

Institutional Backing: Exceptional support with 958 funds—highest institutional coverage in today’s list.

CNTX ($3.17) — Healthcare/Biotechnology

Open full analysis on WaveFinder →

Technical Setup: This biotech breakout shows strong momentum with 8.6% gains and 1.1x relative volume. Trading at demand with no immediate supply overhead creates an attractive risk/reward setup. The 1-hour demand zone at $2.93-$3.10 provides tight stop placement.

Level	Price	Notes
Entry	$3.15-$3.25	Above demand break
Stop Loss	$2.85	Below demand zone
Target	$3.75	Open upside target

Institutional Backing: 27 funds—moderate institutional interest typical for biotech.

LXU ($13.50) — Agriculture/Chemicals-Agricultural

Open full analysis on WaveFinder →

Technical Setup: LXU presents a supply zone test with 5.9% gains on exceptional 2.1x volume. Currently at supply resistance, but strong momentum and B2 bucket classification suggest potential breakout continuation. The weekly supply zone at $13.90-$14.71 represents the key battle zone.

Level	Price	Notes
Entry	$13.45-$13.60	Supply zone hold
Stop Loss	$12.65	Below demand support
Target	$14.85	Above supply break

Institutional Backing: 200 funds with B2 classification indicating solid institutional framework.

Honorable Mentions

• CABO ($114.41): Telecom surge +11.1% on 1.7x volume, testing supply at $115-$117
• MUSA ($444.91): Retail momentum +2.2% at supply resistance with 607 fund backing
• TECX ($34.79): Biotech continuation +4.7% between zones with 141 institutional holders
• TNGX ($16.99): Medical play +3.0% between zones, 218 funds supporting
• BRCB ($16.71): Beverage sector +4.2% at demand with 180 institutional funds

Strategy Summary

Today’s continuation breakouts offer exceptional quality across multiple timeframes and sectors. Energy leads with SOC’s explosive move, while medical and biotech sectors provide multiple opportunities. The mix of high-momentum plays (SOC, DTCX) and steady institutional favorites (MEDP) creates diverse portfolio options. Risk management remains crucial given the elevated ATR levels, but the strong volume confirmation and institutional backing across most picks suggest sustainable momentum. Focus on the energy and healthcare sectors for the highest probability setups.

Signals